Literature DB >> 12672864

Alzheimer's disease and Parkinson's disease.

Robert L Nussbaum1, Christopher E Ellis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672864     DOI: 10.1056/NEJM2003ra020003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  331 in total

1.  T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia.

Authors:  Mohammad Haris; Anup Singh; Kejia Cai; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur
Journal:  J Neurol       Date:  2010-10-07       Impact factor: 4.849

2.  Identification of a dopaminergic enhancer indicates complexity in vertebrate dopamine neuron phenotype specification.

Authors:  Esther Fujimoto; Tamara J Stevenson; Chi-Bin Chien; Joshua L Bonkowsky
Journal:  Dev Biol       Date:  2011-01-27       Impact factor: 3.582

3.  Anti-inflammatory drugs and Alzheimer's disease.

Authors:  Christopher Martyn
Journal:  BMJ       Date:  2003-08-16

4.  Vaccine trial in Alzheimer's disease is halted.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

5.  Treadmill training for individuals with Parkinson disease.

Authors:  Gammon M Earhart; April J Williams
Journal:  Phys Ther       Date:  2012-04-26

Review 6.  Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Authors:  Sagar Kansara; Akash Trivedi; Sheng Chen; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2012-06-26       Impact factor: 3.575

Review 7.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

8.  Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.

Authors:  Sara Hernando; Enara Herran; Joana Figueiro-Silva; José Luis Pedraz; Manoli Igartua; Eva Carro; Rosa Maria Hernandez
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Genetic counseling throughout the life cycle.

Authors:  Leslie J Ciarleglio; Robin L Bennett; Jennifer Williamson; Jessica B Mandell; Joan H Marks
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 10.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.